Borgman Anne Elizabeth 4
4 · SUTRO BIOPHARMA, INC. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2024-03-05+60,000→ 60,000 totalExercise: $4.54Exp: 2034-03-05→ Common Stock (60,000 underlying) - Award
Restricted Stock Units (RSUs)
2024-03-05+45,000→ 45,000 totalExp: 2028-03-01→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.